Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Is AraC Required In the Treatment of Standard Risk APL? Long Term Results of a Randomized Trial (APL 2000) From the French Belgian Swiss APL Group

Blood (2010) 116 (21): 13.

https://doi.org/10.1182/blood.V116.21.13.13

Published: 2010

Journal Articles

Improved Outcome with Androgens as Maintenance Treatment in Elderly Patients with Acute Myeloid Leukemia after ICL Regimen as Induction Therapy: Results of the GOELAMS SA-2002 Multicenter Phase III Randomized Open Trial

Blood (2008) 112 (11): 556.

https://doi.org/10.1182/blood.V112.11.556.556

Published: 2008

Journal Articles

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

Blood (2007) 109 (8): 3489–3495.

https://doi.org/10.1182/blood-2006-08-040410

Published: 2007

Includes: Supplemental data

Journal Articles

A Multicenter Randomized Comparison of Maintenance Treatment with Androgens in Elderly Acute Myeloid Leukemia after ICL Regimen as Induction Therapy: Results of the Goelams-2002 Study.

Blood (2006) 108 (11): 1983.

https://doi.org/10.1182/blood.V108.11.1983.1983

Published: 2006

Journal Articles

Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma

Frederic Garban, Michel Attal, Mauricette Michallet, Cyrille Hulin, Jean H. Bourhis, Ibrahim Yakoub-Agha, Thierry Lamy, Gerald Marit, Frederic Maloisel, Christian Berthou, Mamoun Dib, Denis Caillot, Bernard dePrijck, Nicolas Ketterer, Jean-Luc Harousseau, Jean-Jacques Sotto, Philippe Moreau, for the Intergroupe Francophone du Myélome and the Swiss Group for Clinical Cancer Research

Blood (2006) 107 (9): 3474–3480.

https://doi.org/10.1182/blood-2005-09-3869

Published: 2006

Journal Articles

Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol

Blood (2006) 107 (1): 397–403.

https://doi.org/10.1182/blood-2005-06-2573

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) from a HLA Identical Sibling for CR1 AML Patients Aged above 55 Years Old after a Reduced Intensity Conditioning: A Survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Didier Blaise, Zina Chir, Michel Attal, Jean-Henri Bourhis, Jean-Jacques Sotto, Jean-Michel Boiron, Noel Milpied, Jean-Yves Cahn, Bernard Rio, Bruno Lioure, Francois Guilhot, C. Berthou, Agnes Buzyn, Mauricette Michallet

Blood (2005) 106 (11): 1140.

https://doi.org/10.1182/blood.V106.11.1140.1140

Published: 2005

Journal Articles

Maintenance Treatment with Thalidomide after Autologous Transplantation for Myeloma: Final Analysis of a Prospective Randomized Study of the “Intergroupe Francophone du Myelome”.

Blood (2005) 106 (11): 1148.

https://doi.org/10.1182/blood.V106.11.1148.1148

Published: 2005

Journal Articles

Stem Cell Factor (SCF) for Hematopoietic Stem Cell (HSC) Mobilization: Results of the Randomized IFM 99-01 Trial.

Philippe Bourin, MD/PhD, Anne Huynh, MD, Christian Recher, MD, Christian Berthou, MD, Laurent Garderet, MD, Lofti Benbouker, MD, Anne-Marie Perry, MD, Thierry Facon, MD, Cyrille Hulin, MD, Jean-Jacques Sotto, MD, Laurent Voillat, MD, Mauricette Michallet, MD, Michel Attal, MD.

Blood (2004) 104 (11): 2921.

https://doi.org/10.1182/blood.V104.11.2921.2921

Published: 2004

Journal Articles

Maintenance Treatment with Thalidomide after Autologous Transplantation for Myeloma : First Analysis of a Prospective Randomized Study of the Intergroupe Francophone du Myelome (IFM 99 02).

Michel Attal, MD, Jean-Luc Harousseau, MD, Serge Leyvraz, MD, Chantal Doyen, MD, Cyrille Hulin, MD, Lofti Benboubker, MD, Thierry Facon, MD, Jean-Henri Bourhis, MD, Laurent Garderet, MD, Jean-Jacques Sotto, MD, Mauricette Michallet, MD, Marc Renaud, MD, Laurent Voillat, MD, Christian Berthou, MD, Gerald Marrit, MD, Mathieu Monconduit, MD, Bertrand Coiffier, MD, Denis Caillot, MD

Blood (2004) 104 (11): 535.

https://doi.org/10.1182/blood.V104.11.535.535

Published: 2004

Journal Articles

Early Allogeneic Bone Marrow Transplantation for Young Adults with Acute Myeloid Leukemia in First Complete Remission: The 17 Year Experience of the BGMT Group.

Eric Jourdan, Jean-Michel Boiron, Nicole Dastugue, Norbert Vey, Gérald Marit, Françoise Rigal-Huguet, Lysiane Molina, Nathalie Fegueux, Arnaud Pigneux, Christian Recher, Jean-François Rossi, Michel Attal, Jean-Jacques Sotto, Dominique Maraninchi, Josy Reiffers, Valérie-Jeanne Bardou, Didier Blaise

Blood (2004) 104 (11): 619.

https://doi.org/10.1182/blood.V104.11.619.619

Published: 2004

Journal Articles

Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial

Blood (2004) 104 (10): 3028–3037.

https://doi.org/10.1182/blood-2003-10-3560

Published: 2004

Journal Articles

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

Blood (2004) 103 (2): 435–441.

https://doi.org/10.1182/blood-2003-07-2236

Published: 2004

Journal Articles

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas

Olivier Manches, Gabrielle Lui, Laurence Chaperot, Rémy Gressin, Jean-Paul Molens, Marie-Christine Jacob, Jean-Jacques Sotto, Dominique Leroux, Jean-Claude Bensa, Joël Plumas

Blood (2003) 101 (3): 949–954.

https://doi.org/10.1182/blood-2002-02-0469

Published: 2003

Journal Articles

Comparison of 200 mg/m 2 melphalan and 8 Gy total body irradiation plus 140 mg/m 2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial

Blood (2002) 99 (3): 731–735.

https://doi.org/10.1182/blood.V99.3.731

Published: 2002

Journal Articles

Terminal plasmocytoid differentiation of malignant B cells induced by autotumor-reactive CD4 + T cells in one case of splenic marginal zone B-cell lymphoma

Thierry Bonnefoix, Jian-Qing Mi, Pascal Perron, Mary Callanan, Cosima Semoun, Mireille Favre, Jean-Charles Renversez, Marie-France Sotto, Dominique Leroux, Jean-Jacques Sotto

Blood (2002) 99 (1): 388–390.

https://doi.org/10.1182/blood.V99.1.388

Published: 2002

Journal Articles

Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission

Didier Blaise, Dominique Maraninchi, Mauricette Michallet, Josy Reiffers, Jean Pierre Jouet, Noël Milpied, Agnes Devergie, Michel Attal, Jean Jacques Sotto, Mathieu Kuentz, Norbert Ifrah, Charles Dauriac, Pierre Bordigoni, Nicole Gratecos, François Guilhot, Denis Guyotat, Eliane Gluckman, Jean Paul Vernant

Blood (2001) 97 (11): 3669–3671.

https://doi.org/10.1182/blood.V97.11.3669

Published: 2001

Journal Articles

Identification of a leukemic counterpart of the plasmacytoid dendritic cells

Laurence Chaperot, Nathalie Bendriss, Olivier Manches, Rémy Gressin, Marc Maynadie, Franck Trimoreau, Hubert Orfeuvre, Bernadette Corront, Jean Feuillard, Jean-Jacques Sotto, Jean-Claude Bensa, Francine Brière, Joël Plumas, Marie-Christine Jacob

Blood (2001) 97 (10): 3210–3217.

https://doi.org/10.1182/blood.V97.10.3210

Published: 2001

Journal Articles

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

Blood (1999) 94 (4): 1192–1200.

https://doi.org/10.1182/blood.V94.4.1192

Published: 1999

Journal Articles

Tumor B Cells From Non-Hodgkin's Lymphoma Are Resistant to CD95 (Fas/Apo-1)–Mediated Apoptosis

Joël Plumas, Marie-Christine Jacob, Laurence Chaperot, Jean-Paul Molens, Jean-Jacques Sotto, Jean-Claude Bensa

Blood (1998) 91 (8): 2875–2885.

https://doi.org/10.1182/blood.V91.8.2875.2875_2875_2885

Published: 1998

NARROW

Is AraC Required In the Treatment of Standard Risk APL? Long Term Results of a Randomized Trial (APL 2000) From the French Belgian Swiss APL Group

Improved Outcome with Androgens as Maintenance Treatment in Elderly Patients with Acute Myeloid Leukemia after ICL Regimen as Induction Therapy: Results of the GOELAMS SA-2002 Multicenter Phase III Randomized Open Trial

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

A Multicenter Randomized Comparison of Maintenance Treatment with Androgens in Elderly Acute Myeloid Leukemia after ICL Regimen as Induction Therapy: Results of the Goelams-2002 Study.

Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma

Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol

Allogeneic Stem Cell Transplantation (allo-SCT) from a HLA Identical Sibling for CR1 AML Patients Aged above 55 Years Old after a Reduced Intensity Conditioning: A Survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Maintenance Treatment with Thalidomide after Autologous Transplantation for Myeloma: Final Analysis of a Prospective Randomized Study of the “Intergroupe Francophone du Myelome”.

Stem Cell Factor (SCF) for Hematopoietic Stem Cell (HSC) Mobilization: Results of the Randomized IFM 99-01 Trial.

Maintenance Treatment with Thalidomide after Autologous Transplantation for Myeloma : First Analysis of a Prospective Randomized Study of the Intergroupe Francophone du Myelome (IFM 99 02).

Early Allogeneic Bone Marrow Transplantation for Young Adults with Acute Myeloid Leukemia in First Complete Remission: The 17 Year Experience of the BGMT Group.

Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas

Comparison of 200 mg/m 2 melphalan and 8 Gy total body irradiation plus 140 mg/m 2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial

Terminal plasmocytoid differentiation of malignant B cells induced by autotumor-reactive CD4 + T cells in one case of splenic marginal zone B-cell lymphoma

Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission

Identification of a leukemic counterpart of the plasmacytoid dendritic cells

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

Tumor B Cells From Non-Hodgkin's Lymphoma Are Resistant to CD95 (Fas/Apo-1)–Mediated Apoptosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only